Eating disorders related to obesity

Therapy

Volumn 5, Issue 1, 2008, Pages 109-117

  Vaidya, Varsha ^a   Malik, Abdul ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Neuropsychology Clinic Psych Associates of Maryland   (United States)

Author keywords

Binge eating disorder; Bulimia nervosa; Cognitive behavior therapy; Eating disorders; Obesity; Treatment of eating disorders

Indexed keywords

ANOREXIGENIC AGENT; ANTIDEPRESSANT AGENT; ATOMOXETINE; DEXFENFLURAMINE; DIURETIC AGENT; ESTROGEN RECEPTOR BETA; FLUOXETINE; FLUVOXAMINE; INOSITOL; IPECAC; LAXATIVE; LITHIUM SALT; SEROTONIN 2A RECEPTOR; TOPIRAMATE; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3; VENLAFAXINE;

ADDICTION; ANOREXIA NERVOSA; BINGE EATING DISORDER; BULIMIA; COGNITIVE THERAPY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; EATING DISORDER; FAMILY THERAPY; HUMAN; IMPULSE CONTROL DISORDER; MENSTRUAL IRREGULARITY; MENTAL DISEASE; MORBIDITY; MORTALITY; OBESITY; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT;

EID: 38349179168     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/14750708.5.1.109     Document Type: Review

References (43)

1. Wang Y, Beydoun MA: The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiology Rev. 29, 6-28 (2007).
2. Finkelstein EA, Fiebelkom IC, Wang G: State-level estimates of annual medical expenditures attributable to obesity. Obes. Res. 12, 18-24 (2004).
3. Flament M, Ledoux S, Jeamet P et al.: A Population Study of Bulimia Nervosa and Subdinical. Eating Disorder in Adolescence. In: Eating disorders in Adolescence: Anorexia and Bulimia Nervosa. Steinhausen HC (Ed.), Walter De Gruyter Inc., NY, USA, 21-36 (1995).
4. Klump KL, Kaye WH, Strober M: The evolving genetic foundations of eating. Psychiatr. Clin. North Am. 24(2). 215-225 (2001).
5. Schmidt U, Tiller J, Treasure J: Psychosocial factors in the origins of bulimia nervosa. Int. Rev. Psychatry 5, 51-60 (1993).
6. Fairburn CG, Cooper PJ: The clinical features of bulimia nervosa. Br. J. Psychiatry 144, 238-246 (1984).
7. Shav, HE, Stice E, Springer DW: Perfectionism, body dissatisfaction, and self-esteem in predicting bulimic symptomatology: lack of replication. Int. J. Eat. Disord. 36(1), 41-47 (2004).
8. Hoek HW, Bartelds AIM. Bosveld JJF et al.: Impact of urbanization an detection rates of eating disorders. Am. J. Psychiatry 152, 1272-1278 (1995).
9. Mitchell JE, Pomeroy C, Huber M: A cliniciar;s guide to the eating disorders medicine cabinet. Int. J. Eat. Disord. 7. 211-223 (1988).
10. Raphael FJ, Rodin DA, Peattie A et al.: Ovarian morphology and insulin sensitivity in women with bullmia nervosa. Clin. Endocrinal. 43, 451-455 (1995).
11. Glendale KA, Bulk CM, Joyce PR et al.: Menstrual cycle irregularity in bulimia nervosa. Associated factors and changes with treatment. J. Psychosom. Res. 49, 409-415 (2000).
12. Wilson GT. Cognitive behavior therapy for eating disorders: progress and problems. Behav. Res. Ther. 37, S79-S95 (1999).
13. Fairburn CG, Norman PA, Welch SL: A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments. Arch. Gen. Psychiatry 52, 304-312 (1995).
14. Kotler LA, Walsh BT: Eating disorders in children and adolescents: pharmacological therapies. Eur. Child Adolesc Psychiatry 9 (Suppi. 1), 1108-1116 (2000).
15. Agras WS: Pharmacotherapy of bulimia nervosa and binge eating disorder: longer term outcomes. Psychopharmacol. Bull. 33, 433-436 (1997).
16. Walsh BT, Agras WS, Devlin MJ et al.: Fluoxetine for bulimia nervosa following poor response to psychotherapy. Am. J. Psychiatry 157, 1332-1334 (2000).
17. Van Furth EF, Van Strien DC, Martina LM et al.: Expressed emotion and prediction of outcome in adolescent eating disorders. Int. J. Eat. Disord. 20, 19-31 (1996).
18. Keel PK, Mitchell JE, Miller KB et al.: Long-term out come in bulimia nervosa. Arch. Gen. Psychiatry 56, 63-69 (1999).
19. Stunkard AJ: Eating patterns and obesity. Psychiatr. Q. 33, 284-292 (1959).
20. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. APA Press, Washington, DC, USA (1994).
21. Vaidya V: Prevalence of binge eating disorder in patients seeking bariatric surgery, and its correlation with personality characteristics. (2007) (In Press).
22. Strieber-Moore RH, Wilson GT Wifely DE et al.: Binge eating in an obese community sample. Int. J. Eat. Disord. 23, 27-37 (1998).
23. Fitzgibbon ML, Spring B, Avalon ME, Blackman LR: Correlates of binge eating in Hispanic black and white women. Int. J. Eat. Disord. 24, 43-52 (1998).
24. Raymond NC, Mussell MP, Mitchell JE et al.: An age matched comparison of subjects with binge eating disorder and bulimia nervosa. Int. J. Eat. Disord. 18, 135-143 (1995).
25. Grillo CM, Masheb RM: Onset of dieting vs binge eating. Int. J. Obes. 24, 404-409 (2000).
26. Marcus MD, Moulton MM, Greeno CG: Binge eating onset in obese patients with binge eating disorder. Addict. Behav. 20, 747-755 (1995).
27. Spurrell EB, Wilfley DE, Tanofsky MB, Brownell KD: Age of onset for binge eating. Are there different pathways to binge eating? Int. J. Eat. Disord. 21, 55-65 (1997).
28. Mitchell JE, Mussell MP: Comorbidity and binge eating disorder. Addict. Behav. 20, W725-732 (1992).
29. Gustafson TB, Sarwer DB: Childhood sexual abuse and obesity. Obes. Rev. 5(3), 129-135 (2004).
30. Jackson TD, Grilo CM, Masheb RM: Teasing history, onset of obesity, current eating disorder psychopathology, and psychological functioning in binge eating disorder. Obes. Res. 8(6), 108-113 (2000).
31. Fairburn CG, Doll HA, Welch SL et al.: Risk factors for binge eating disorders - a community-based case control study. Arch. Gen. Psychiatry 55, 425-432 (1998).
32. Barlow SE, Dietz WH: Obesity evaluation and treatment: expert committee recommendations. Pediatrics 102, E29 (1998).
33. de Zwaan M, Mitchell JE, Seim HC et al.: Eating related and general psychopathology in obese females with binge eating disorder. Int. J. Eat. Disord. 15(1), 43-52 (1994).
34. Hudson JI, McElroy SL, Raymond NC et al.: Fluvoxamine in the treatment of binge eating disorder. A multi-center, double blind placebo controlled trial. Am. J. Psychiatry 155, 1756-1762 (1998).
35. Malhotra S, King KH, Welge JA, Brusman-Lovins L, McElroy SL: Venlafaxine treatment of binge eating disorder associated with obesity. J. Clin. Psychiatry 63, 802-806 (2002).
36. McElroy SL, Guerdjikova A, Kotwal R et al.: Atomoxetine in the treatment of binge eating disorder: a randomized placebo controlled trial. J. Clin. Psychiatry 68, 390-398 (2007).
37. Claudino AM, de Oliveira IR, Appolinario JC et al.: Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. J. Clin. Psychiatry 68(9), 1324-1332 (2007).
38. Loeb KL, Wilson GT, Gilbert JS, Labouvie E: Guided and unguided self help in binge eating. Behav. Res. Ther. 38, 259-272 (2000).
39. Agras WS, Telch CF, Arnow B et al.: Weight loss, cognitive behavior therapy, and desimipramine treatments in binge eating disorder. An additive design. Behav. Ther. 25, 225-238 (1994).
40. Blaine B, Rodman J: Responses to weight loss treatment among obese individuals with and without BED: a matched-study meta-analysis. Eat. Weight Disord. 12(2), 54-60 (2007).
41. Fairburn CG, Cooper Z, Doll HA et al.: The natural course of bulimia nervosa and binge eating disorder in young women. Arch. Gen. Psych. 57, 659-665 (2000).
42. Mitchell JE, Mussell MP, Peterson CB et al.: Hedonics of binge eating in women with bulimia nervosa and binge eating disorder. Int. J. Eat. Disord. 26, 165-170 (1999).
43. Decaluwe V, Brae C: The cognitive behavioral model for eating disorders: a direct evaluation in children and adolescents with obesity. Eat. Behav. 6, 211-220 (2005).